Shattuck Labs Inc
NASDAQ:STTK

Watchlist Manager
Shattuck Labs Inc Logo
Shattuck Labs Inc
NASDAQ:STTK
Watchlist
Price: 1.005 USD -0.5% Market Closed
Market Cap: 48m USD
Have any thoughts about
Shattuck Labs Inc?
Write Note

Intrinsic Value

The intrinsic value of one STTK stock under the Base Case scenario is 1.148 USD. Compared to the current market price of 1.005 USD, Shattuck Labs Inc is Undervalued by 12%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

STTK Intrinsic Value
1.148 USD
Undervaluation 12%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Shattuck Labs Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for STTK cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about STTK?
Bearish
Neutral
Bullish

Fundamental Analysis

Economic Moat
Shattuck Labs Inc

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Shattuck Labs Inc

Provide an overview of the primary business activities
of Shattuck Labs Inc.

What unique competitive advantages
does Shattuck Labs Inc hold over its rivals?

What risks and challenges
does Shattuck Labs Inc face in the near future?

Has there been any significant insider trading activity
in Shattuck Labs Inc recently?

Summarize the latest earnings call
of Shattuck Labs Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Shattuck Labs Inc.

Provide P/S
for Shattuck Labs Inc.

Provide P/E
for Shattuck Labs Inc.

Provide P/OCF
for Shattuck Labs Inc.

Provide P/FCFE
for Shattuck Labs Inc.

Provide P/B
for Shattuck Labs Inc.

Provide EV/S
for Shattuck Labs Inc.

Provide EV/GP
for Shattuck Labs Inc.

Provide EV/EBITDA
for Shattuck Labs Inc.

Provide EV/EBIT
for Shattuck Labs Inc.

Provide EV/OCF
for Shattuck Labs Inc.

Provide EV/FCFF
for Shattuck Labs Inc.

Provide EV/IC
for Shattuck Labs Inc.

Show me price targets
for Shattuck Labs Inc made by professional analysts.

What are the Revenue projections
for Shattuck Labs Inc?

How accurate were the past Revenue estimates
for Shattuck Labs Inc?

What are the Net Income projections
for Shattuck Labs Inc?

How accurate were the past Net Income estimates
for Shattuck Labs Inc?

What are the EPS projections
for Shattuck Labs Inc?

How accurate were the past EPS estimates
for Shattuck Labs Inc?

What are the EBIT projections
for Shattuck Labs Inc?

How accurate were the past EBIT estimates
for Shattuck Labs Inc?

Compare the revenue forecasts
for Shattuck Labs Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Shattuck Labs Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Shattuck Labs Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Shattuck Labs Inc compared to its peers.

Compare the P/E ratios
of Shattuck Labs Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Shattuck Labs Inc with its peers.

Analyze the financial leverage
of Shattuck Labs Inc compared to its main competitors.

Show all profitability ratios
for Shattuck Labs Inc.

Provide ROE
for Shattuck Labs Inc.

Provide ROA
for Shattuck Labs Inc.

Provide ROIC
for Shattuck Labs Inc.

Provide ROCE
for Shattuck Labs Inc.

Provide Gross Margin
for Shattuck Labs Inc.

Provide Operating Margin
for Shattuck Labs Inc.

Provide Net Margin
for Shattuck Labs Inc.

Provide FCF Margin
for Shattuck Labs Inc.

Show all solvency ratios
for Shattuck Labs Inc.

Provide D/E Ratio
for Shattuck Labs Inc.

Provide D/A Ratio
for Shattuck Labs Inc.

Provide Interest Coverage Ratio
for Shattuck Labs Inc.

Provide Altman Z-Score Ratio
for Shattuck Labs Inc.

Provide Quick Ratio
for Shattuck Labs Inc.

Provide Current Ratio
for Shattuck Labs Inc.

Provide Cash Ratio
for Shattuck Labs Inc.

What is the historical Revenue growth
over the last 5 years for Shattuck Labs Inc?

What is the historical Net Income growth
over the last 5 years for Shattuck Labs Inc?

What is the current Free Cash Flow
of Shattuck Labs Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Shattuck Labs Inc.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Shattuck Labs Inc

Current Assets 98.7m
Cash & Short-Term Investments 90.1m
Other Current Assets 8.7m
Non-Current Assets 13m
PP&E 10.8m
Other Non-Current Assets 2.2m
Current Liabilities 12.4m
Accounts Payable 2.9m
Accrued Liabilities 7.9m
Other Current Liabilities 1.6m
Non-Current Liabilities 2.7m
Other Non-Current Liabilities 2.7m
Efficiency

Earnings Waterfall
Shattuck Labs Inc

Revenue
6.4m USD
Operating Expenses
-86.3m USD
Operating Income
-79.9m USD
Other Expenses
5.5m USD
Net Income
-74.4m USD

Free Cash Flow Analysis
Shattuck Labs Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Earnings Calls

As of the third quarter's end in 2023, the company reported a robust financial stance with $101.1 million in cash, investments, and equivalents. R&D expenses rose to $24.2 million, compared to the prior year's $18.9 million, while G&A expenses dropped to $5.1 million from $6.6 million. The net loss widened slightly to $27.5 million. Importantly, financial guidance reaffirms sufficient funds to end of 2024. In clinical developments, exciting data results are forthcoming for the CD47 agent 154 in AML and higher-risk MDS, with potential to be first to market pending outcomes of future trials.

What is Earnings Call?
Fundamental Scores

STTK Profitability Score
Profitability Due Diligence

Shattuck Labs Inc's profitability score is 26/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Years Revenue Growth
Exceptional 1-Year Revenue Growth
ROIC is Increasing
Declining ROE
26/100
Profitability
Score

Shattuck Labs Inc's profitability score is 26/100. The higher the profitability score, the more profitable the company is.

STTK Solvency Score
Solvency Due Diligence

Shattuck Labs Inc's solvency score is 61/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Low D/E
Low Altman Z-Score
61/100
Solvency
Score

Shattuck Labs Inc's solvency score is 61/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

STTK Price Targets Summary
Shattuck Labs Inc

Wall Street analysts forecast STTK stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for STTK is 2.04 USD with a low forecast of 2.02 USD and a high forecast of 2.1 USD.

Lowest
Price Target
2.02 USD
101% Upside
Average
Price Target
2.04 USD
103% Upside
Highest
Price Target
2.1 USD
109% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for STTK?

Click here to dive deeper.

Dividends

Shattuck Labs Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for STTK is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

STTK Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Profile

Shattuck Labs Inc Logo
Shattuck Labs Inc

Country

United States of America

Industry

Biotechnology

Market Cap

48m USD

Dividend Yield

0%

Description

Shattuck Labs, Inc. engages in the research and development of Agonist Redirected Checkpoint (ARC) platform. The company is headquartered in Austin, Texas and currently employs 85 full-time employees. The company went IPO on 2020-10-09. The firm is engaged in the development of dual-sided fusion proteins. The firm has created an approach to immune modulation by designing biologics with structural characteristics. Compounds derived from its Agonist Redirected Checkpoint (ARC) platform simultaneously inhibit checkpoint molecules and activate costimulatory molecules within a single therapeutic. Its lead product candidate, SL-172154, is designed to simultaneously inhibit the cluster of differentiation 47/signal regulatory protein alpha (CD47/SIRPa) checkpoint interaction to restore an anti-tumor immune response and to activate the cluster of differentiation 40 (CD40) costimulatory receptor to bolster an immune response. The firm's second product candidate, SL-279252, is designed to simultaneously inhibit the programmed death-1/programmed death-ligand 1 (PD-1/PD-L1) interaction and activate the OX40 receptor.

Contact

TEXAS
Austin
500 W. 5Th Street, Suite 100
+15129004690.0
www.shattucklabs.com

IPO

2020-10-09

Employees

85

Officers

Co-Founder, CEO & Director
Dr. Taylor H. Schreiber M.D., Ph.D.
Chief Financial Officer
Mr. Andrew R. Neill M.B.A.
Chief Medical Officer
Dr. Arunthathy Nirmalini Pandite M.B.A., M.D.
Chief Technical Officer
Dr. Abhinav A. Shukla Ph.D.
Vice President of Investor Relations
Mr. Conor Richardson CPA
General Counsel, Corporate Secretary and Chief Ethics & Compliance Officer
Dr. Stephen Stout J.D., Ph.D.
Show More
Chief Business Officer
Ms. Casi DeYoung
Senior Vice President of Regulatory Affairs
Dr. Thomas Lampkin Pharm.D.
Co-Chief Scientific Officer
Mr. Suresh de Silva Ph.D.
Show Less

See Also

Discover More
What is the Intrinsic Value of one STTK stock?

The intrinsic value of one STTK stock under the Base Case scenario is 1.148 USD.

Is STTK stock undervalued or overvalued?

Compared to the current market price of 1.005 USD, Shattuck Labs Inc is Undervalued by 12%.

Back to Top